Nutri Pharmaceuticals Research NRPR Stock
Nutri Pharmaceuticals Research Price Chart
Nutri Pharmaceuticals Research NRPR Financial and Trading Overview
| Nutri Pharmaceuticals Research stock price | 0.02 USD |
| Previous Close | 0.01 USD |
| Open | 0.01 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.01 - 0.01 USD |
| 52 Week Range | 0.01 - 0.05 USD |
| Volume | 1.38K USD |
| Avg. Volume | 1.42K USD |
| Market Cap | 12.39K USD |
| Beta (5Y Monthly) | -1.883802 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.654 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
NRPR Valuation Measures
| Enterprise Value | 49.72K USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.010228581 |
| Price/Book (mrq) | 0.3 |
| Enterprise Value/Revenue | 0.041 |
| Enterprise Value/EBITDA | -0.117 |
Trading Information
Nutri Pharmaceuticals Research Stock Price History
| Beta (5Y Monthly) | -1.883802 |
| 52-Week Change | -68.94% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.05 USD |
| 52 Week Low | 0.01 USD |
| 50-Day Moving Average | 0.02 USD |
| 200-Day Moving Average | 0.03 USD |
NRPR Share Statistics
| Avg. Volume (3 month) | 1.42K USD |
| Avg. Daily Volume (10-Days) | 137 USD |
| Shares Outstanding | 938.62K |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2003 |
| Most Recent Quarter (mrq) | December 31, 2003 |
| Next Fiscal Year End | December 31, 2004 |
Profitability
| Profit Margin | -38.60% |
| Operating Margin (ttm) | -38.25% |
| Gross Margin | 42.07% |
| EBITDA Margin | -34.95% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 1.21M USD |
| Revenue Per Share (ttm) | 1.69 USD |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 18.95K USD |
| EBITDA | -423340 USD |
| Net Income Avi to Common (ttm) | -467592 USD |
| Diluted EPS (ttm) | -0.654 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 90.07K USD |
| Total Cash Per Share (mrq) | 0.09 USD |
| Total Debt (mrq) | 125.86K USD |
| Total Debt/Equity (mrq) | 52.81 USD |
| Current Ratio (mrq) | 0.719 |
| Book Value Per Share (mrq) | 0.044 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 22.68K USD |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Nutri Pharmaceuticals Research
| Country | United States |
| State | NV |
| City | Las Vegas |
| Address | 6780 Caballo Street |
| ZIP | 89119 |
| Phone | 702-479-1028 |
| Website | https://www.o2pus.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Nutri Pharmaceuticals Research, Inc. engages in the manufacture and sale of health, beauty, and food ingredients, as well as vitamins and supplements worldwide. It also develops a process that transforms edible oils into a free-flowing powder form. The company uses its oil to powder' products as ingredients in finished goods, such as food, pet food, nutraceuticals or vitamin supplements, cosmetics, and organic household products. Nutri Pharmaceuticals is based in Las Vegas, Nevada.
Q&A For Nutri Pharmaceuticals Research Stock
What is a current NRPR stock price?
Nutri Pharmaceuticals Research NRPR stock price today per share is 0.02 USD.
How to purchase Nutri Pharmaceuticals Research stock?
You can buy NRPR shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Nutri Pharmaceuticals Research?
The stock symbol or ticker of Nutri Pharmaceuticals Research is NRPR.
Which industry does the Nutri Pharmaceuticals Research company belong to?
The Nutri Pharmaceuticals Research industry is Drug Manufacturers-Specialty & Generic.
How many shares does Nutri Pharmaceuticals Research have in circulation?
The max supply of Nutri Pharmaceuticals Research shares is 105.31M.
What is Nutri Pharmaceuticals Research Price to Earnings Ratio (PE Ratio)?
Nutri Pharmaceuticals Research PE Ratio is now.
What was Nutri Pharmaceuticals Research earnings per share over the trailing 12 months (TTM)?
Nutri Pharmaceuticals Research EPS is -0.654 USD over the trailing 12 months.
Which sector does the Nutri Pharmaceuticals Research company belong to?
The Nutri Pharmaceuticals Research sector is Healthcare.